pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Marketed
elafibranor
Iqirvo (elafibranor)
Primary Sclerosing Cholangitis
Ipsen SA
Marketed
elagolix sodium + estradiol + norethindrone + elagolix sodium
Oriahnn (elagolix sodium + estradiol + norethindrone + elagolix sodium)
Menorrhagia
$ABBV
AbbVie Inc.
Marketed
elapegademase
Revcovi (elapegademase-lvlr)
Adenosine Deaminase (ADA) Deficiency Related SCID
Leadiant Biosciences Inc
← prev
page 174 of 231
next →
131
Pain
89
Neurology
1
Marketed
elasomeran
Spikevax (elasomeran [INN])
Coronavirus Disease 2019 (COVID-19)
$MRNA
Moderna, Inc.
Phase 3
elebsiran
elebsiran
Hepatitis D
$VIR
Vir Biotechnology, Inc.
Phase 3
elebsiran + tobevibart
elebsiran + tobevibart
Hepatitis D
$VIR
Vir Biotechnology, Inc.
Phase 2
elecoglipron
elecoglipron
Type 2 Diabetes
$AZN
ASTRAZENECA PLC
Phase 3
elegrobart
elegrobart
Graves' Ophthalmopathy
Viridian Therapeutics Inc
Phase 3
elenestinib
elenestinib
Systemic Mastocytosis
Blueprint Medicines Corp
Preclinical
elesclomol
elesclomol
Endometrial Cancer
Edison Oncology Holding Corp
Marketed
eletriptan hydrobromide
Eletriptan Hydrobromide
Migraine
Beximco Pharmaceuticals USA Inc
Phase 2
elezanumab
elezanumab
Traumatic Spinal Cord Injury
$ABBV
AbbVie Inc.
Phase 3
elfucose
elfucose
Inherited Metabolic Disorders
AUG Therapeutics LLC
Phase 2
elifactant
elifactant
Neonatal Respiratory Distress Syndrome
Chiesi Farmaceutici SpA
Marketed
eliglustat tartrate
Eliglustat Tartrate
Gaucher Disease Type I
Aizant Drug Research Solutions Pvt Ltd
Marketed
elinzanetant
Lynkuet (elinzanetant)
Vasomotor Symptoms of Menopause (Hot Flashes)
Bayer USA LLC
Phase 2
elironrasib
elironrasib
Non-Small Cell Lung Cancer
$RVMD
Revolution Medicines, Inc.
Phase 2
elisrasib
elisrasib [INN]
Solid Tumor
D3 Bio Inc
Marketed
elivaldogene autotemcel
Skysona (elivaldogene autotemcel [INN])
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD))
Genetix Biotherapeutics Inc
Marketed
elosulfase alfa
Vimizim (elosulfase alfa)
Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome )
$BMRN
BIOMARIN PHARMACEUTICAL INC
Marketed
elotuzumab
Empliciti (elotuzumab)
Refractory Multiple Myeloma
Bristol-Myers Squibb Co
Phase 2
elraglusib
elraglusib
Neuroblastoma
$ACTU
ACTUATE THERAPEUTICS, INC.
Phase 3
elritercept
elritercept
Anemia
$TAK
TAKEDA PHARMACEUTICAL CO LTD
Phase 3
elsunersen
elsunersen [INN]
Epileptic Encephalopathy
$PRAX
Praxis Precision Medicines, Inc.
Phase 1
eltanolone
eltanolone [INN]
Epilepsy
$LPCN
Lipocine Inc.
Phase 2
eltivutabart
eltivutabart [INN]
Pancreatic Ductal Adenocarcinoma
Trishula Therapeutics Inc
Phase 2
elunetirom
elunetirom
Bipolar I Disorder
Autobahn Therapeutics Inc
Marketed
eluxadoline
Viberzi (eluxadoline)
Diarrhea
$ABBV
AbbVie Inc.
Phase 2
elzovantinib
elzovantinib
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
Phase 3
emactuzumab
emactuzumab
Tenosynovial Giant Cell Tumor
SynOx Therapeutics Ltd